Trials / Unknown
UnknownNCT03653000
Assessement of a Novel Approach to Ultrasound-guided Brachial Plexus Blockade
Assessement of a Novel Approach to Ultrasound-guided Brachial Plexus Blockade, Located Between the Infraclavicular and the Axillary Site
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Assessement of a new approach of an ultrasound guided brachial plexus blockade between the infraclavicular and axillary area.
Detailed description
After an assessement of this new approach of ultrasounded-guided brachial plexus blockade in cadavers, the aim of this human study was to asssess the validity of this method in humans. The probe will be disposed on the shoulder, and the brachial plexus will be seeked below the deltoid, lateral to the major pectoralis muscle and in the vicinity of the brachial artery. At this area, an ultrasounded guided needle was inserted with an in-plane direction towards the brachial artery and local anesthetics was disposed all around the artery, without puncturing the differents nerves. Regional blockade will be evaluated by measuring onset and duation time for sensitive and motor blockade, effectiveness of this blockade, patient's confort during the procedure, ease of the procedure for practitionner, quality of ultrasound image's interpretation before and after injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ultrasound guided brachial plexus blockade | Ultrasound probe disposed on the shoulder, on the deltoid muscle. in plane puncture toward the brachial artery and injection of local anaesthetics around the brachial artery |
| DRUG | local anaesthetic injection | Local anesthetic injection (ropivacaine) at this new site |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2018-08-31
- Last updated
- 2022-06-22
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03653000. Inclusion in this directory is not an endorsement.